Terms: = Breast cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
21 results:
1. New treatment strategies for human epidermal growth factor receptor 2-positive breast cancer in 2023.
Banys-Paluchowski M; Krawczyk N; Stickeler E; Müller V; Fehm T
Curr Opin Obstet Gynecol; 2023 Feb; 35(1):54-61. PubMed ID: 36239554
[TBL] [Abstract] [Full Text] [Related]
2. Percutaneous Management of breast cancer: a Systematic Review.
Dai Y; Liang P; Yu J
Curr Oncol Rep; 2022 Nov; 24(11):1443-1459. PubMed ID: 35699836
[TBL] [Abstract] [Full Text] [Related]
3. Endoscopy-Assisted Total Mastectomy with and without Immediate Reconstruction: An Extended Follow-Up, Multicenter Study.
Kuo YL; Chang CH; Chang TY; Chien HF; Liao LM; Hung CS; Lin SL; Chen ST; Chen DR; Lai HW
Plast Reconstr Surg; 2021 Feb; 147(2):267-278. PubMed ID: 33165292
[TBL] [Abstract] [Full Text] [Related]
4. Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.
Lende TH; Austdal M; Bathen TF; Varhaugvik AE; Skaland I; Gudlaugsson E; Egeland NG; Lunde S; Akslen LA; Jonsdottir K; Janssen EAM; Søiland H; Baak JPA
BMC Cancer; 2019 Dec; 19(1):1183. PubMed ID: 31801490
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine: Changing the Treatment Paradigms.
Goodwin CR; Abu-Bonsrah N; Rhines LD; Verlaan JJ; Bilsky MH; Laufer I; Boriani S; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S218-S223. PubMed ID: 27488299
[TBL] [Abstract] [Full Text] [Related]
6. Single-stage breast reconstruction using Strattice™: A retrospective study.
Dikmans RE; El Morabit F; Ottenhof MJ; Tuinder SM; Twisk JW; Moues C; Bouman MB; Mullender MG
J Plast Reconstr Aesthet Surg; 2016 Feb; 69(2):227-33. PubMed ID: 26723835
[TBL] [Abstract] [Full Text] [Related]
7. Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene.
Savas P; Caramia F; Teo ZL; Loi S
Curr Opin Oncol; 2014 Nov; 26(6):562-7. PubMed ID: 25188474
[TBL] [Abstract] [Full Text] [Related]
8. Circulating Tumor Cells Count and Morphological Features in breast, Colorectal and Prostate cancer.
Ligthart ST; Coumans FA; Bidard FC; Simkens LH; Punt CJ; de Groot MR; Attard G; de Bono JS; Pierga JY; Terstappen LW
PLoS One; 2013; 8(6):e67148. PubMed ID: 23826219
[TBL] [Abstract] [Full Text] [Related]
9. clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
[TBL] [Abstract] [Full Text] [Related]
10. Phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibition: a breakthrough in the management of luminal (ER+/HER2-) breast cancers?
Zardavas D; Fumagalli D; Loi S
Curr Opin Oncol; 2012 Nov; 24(6):623-34. PubMed ID: 22960556
[TBL] [Abstract] [Full Text] [Related]
11. Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer.
Verma R; Bowen RL; Slater SE; Mihaimeed F; Jones JL
Br Med Bull; 2012 Sep; 103(1):129-45. PubMed ID: 22864058
[TBL] [Abstract] [Full Text] [Related]
12. Surgery followed by radiotherapy for the treatment of metastatic epidural spinal cord compression from breast cancer.
Tancioni F; Navarria P; Mancosu P; Pedrazzoli P; Morenghi E; Santoro A; Baena RR; Scorsetti M
Spine (Phila Pa 1976); 2011 Sep; 36(20):E1352-9. PubMed ID: 21358472
[TBL] [Abstract] [Full Text] [Related]
13. The breast cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer.
Toi M; Ohashi Y; Seow A; Moriya T; Tse G; Sasano H; Park BW; Chow LW; Laudico AV; Yip CH; Ueno E; Ishiguro H; Bando H
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i13-18. PubMed ID: 20870914
[TBL] [Abstract] [Full Text] [Related]
14. Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.
Capala J; Bouchelouche K
Curr Opin Oncol; 2010 Nov; 22(6):559-66. PubMed ID: 20842031
[TBL] [Abstract] [Full Text] [Related]
15. Circulating tumor cells and emerging blood biomarkers in breast cancer.
Criscitiello C; Sotiriou C; Ignatiadis M
Curr Opin Oncol; 2010 Nov; 22(6):552-8. PubMed ID: 20706122
[TBL] [Abstract] [Full Text] [Related]
16. Circulating tumor cells in breast cancer.
Ignatiadis M; Georgoulias V; Mavroudis D
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
[TBL] [Abstract] [Full Text] [Related]
17. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
[TBL] [Abstract] [Full Text] [Related]
18. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract] [Full Text] [Related]
19. Ductal carcinoma in situ: a review of recent advances.
Tang P; Hajdu SI; Lyman GH
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):63-7. PubMed ID: 17218854
[TBL] [Abstract] [Full Text] [Related]
20. Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies.
Sauer G; Deissler H
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):45-9. PubMed ID: 12544501
[TBL] [Abstract] [Full Text] [Related]
[Next]
